Innovation Under Pressure: Transatlantic Biotech in a Changing World
A transatlantic lens into how investors, pharma and founders navigate the current innovation landscape
Join us for an incredible evening of insight into the current landscape of biotech innovation, explored through the perspectives of investors, founders and pharma.
This event brings together life science entrepreneurs, venture capitalists, and representatives from the pharmaceutical industry for an engaging discussion and networking opportunity at today's intersection of science, business, and innovation.
A transatlantic lens into how investors, pharma and founders navigate the current innovation landscape
Join us for an incredible evening of insight into the current landscape of biotech innovation, explored through the perspectives of investors, founders and pharma.
This event brings together life science entrepreneurs, venture capitalists, and representatives from the pharmaceutical industry for an engaging discussion and networking opportunity at today's intersection of science, business, and innovation.
Speakers Include
- Mridul Agrawal, Managing Director & Co-Founder, iuvando Health
- Jens Eckstein, Biotech Founder and Investor
- Alberto Nobili, Head of Bayer Co.Lab, Cambridge
- Stella Paffenholz, Principal, Nextech
- Markus Warmuth, Biotech Founder, CEO Monte Rosa Therapeutics
The discussion will be followed by networking.
Email Policy
When you register for a GABC event, your email address will be automatically added to our list of contacts, which will be used to send you future event invitations and news. You can unsubscribe from that list at any time.
Photography
By attending a GABC event, whether as a participant or otherwise, you consent that images may be captured during the event using digital photography, video or other medium and may be used by GABC to promote the organization's work, or other future events via their website, social media channels, promotional leaflets and brochures and Orother publicity material (such as internal and external newsletters).